Sökning: WFRF:(Schultzberg Marianne) >
Homocysteine Status...
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease : The OmegAD Study
-
- Jernerén, Fredrik (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Cederholm, Tommy (författare)
- Karolinska Institutet,Uppsala universitet,Geriatrik,Karolinska Univ Hosp, Theme Ageing, Stockholm, Sweden
-
- Refsum, Helga (författare)
- Department of Nutrition, University of Oslo, Oslo, Norway; Department of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oslo, Dept Nutr, Oslo, Norway;Univ Oxford, Dept Pharmacol, Oxford, England
-
visa fler...
-
- Smith, A. David (författare)
- Department of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oxford, Dept Pharmacol, Oxford, England
-
- Turner, Cheryl (författare)
- Department of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oxford, Dept Pharmacol, Oxford, England
-
- Palmblad, Jan (författare)
- Karolinska Institutet
-
- Eriksdotter, Maria (författare)
- Karolinska Institutet
-
- Hjorth, Erik (författare)
- Karolinska Institutet
-
- Faxen-Irving, Gerd (författare)
- Karolinska Institutet
-
- Wahlund, Lars-Olof (författare)
- Karolinska Institutet
-
- Schultzberg, Marianne (författare)
- Karolinska Institutet
-
- Basun, Hans (författare)
- Uppsala universitet,Geriatrik
-
- Freund-Levi, Yvonne, 1956- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden; Department of Psychiatry in Region Örebro County and School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro; Department of Old Age Psychiatry, Psychology & Neuroscience, King’s College, London, UK,Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden;Karolinska Inst, Ctr Alzheimer Res, Div Clin Geriatr, Huddinge, Sweden;Orebro Univ, Dept Psychiat Reg Orebro Cty, Fac Med & Hlth, Orebro, Sweden;Orebro Univ, Sch Med Sci, Fac Med & Hlth, Orebro, Sweden;Kings Coll London, Dept Old Age Psychiat Psychol & Neurosci, London, England
-
visa färre...
-
(creator_code:org_t)
- IOS Press, 2019
- 2019
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - : IOS Press. - 1387-2877 .- 1875-8908. ; 69:1, s. 189-197
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Trials of supplementation with omega-3 fatty acids (omega 3-FAs) in patients with mild cognitive impairment or Alzheimer's disease (AD) have produced inconsistent effects on cognitive decline. There is evidence of an interaction between B vitamin status and omega 3-FAs in relation to brain atrophy and cognitive decline.Objective: We investigated whether baseline levels of plasma total homocysteine (tHcy), a marker of B vitamin status, modify the effects of omega 3-FAs supplementation on cognitive performance in moderate AD.Methods: This post hoc analysis of the OmegAD trial included 171 community-based patients with AD (MMSE >= 15): 88 patients received daily doses of 1.7 g docosahexaenoic acid and 0.6 g eicosapentaenoic acid for 6 months. Treatment outcome on cognition was analyzed according to baseline levels of tHcy using a general linear model and ANCOVA.Results: We found significant interactions between omega 3-FA supplementation and tHcy on cognition and clinical stage assessed by MMSE (p = 0.040), global CDR (p = 0.059), and CDRsob (p = 0.023), but not on ADAS-cog (p = 0.649). In patients with tHcy levels <11.7 mu mol/L, omega 3-FA supplementation improved cognitive performance as measured by MMSE (+7.1%, 95% CI: 0.59 to 13.7%, p = 0.033) and clinical status as measured by CDRsob (-22.3%, 95% CI: -5.8 to -38.7%, p = 0.009) compared with placebo.Conclusion: The effect of omega 3-FA supplementation on MMSE and CDR appears to be influenced by baseline tHcy, suggesting that adequate B vitamin status is required to obtain beneficial effects of omega 3-FA on cognition.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- Alzheimer's disease
- B vitamins
- cognition
- dementia
- homocysteine
- omega-3 fatty acids
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Jernerén, Fredri ...
-
Cederholm, Tommy
-
Refsum, Helga
-
Smith, A. David
-
Turner, Cheryl
-
Palmblad, Jan
-
visa fler...
-
Eriksdotter, Mar ...
-
Hjorth, Erik
-
Faxen-Irving, Ge ...
-
Wahlund, Lars-Ol ...
-
Schultzberg, Mar ...
-
Basun, Hans
-
Freund-Levi, Yvo ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Örebro universitet
-
Uppsala universitet
-
Karolinska Institutet